Display Settings:

Format

Send to:

Choose Destination
J Virol. 1989 Nov;63(11):4969-71.

Antiviral effect of lymphokine-activated killer cells: chemotaxis and homing to sites of virus infection.

Author information

  • 1Department of Pathology, University of Massachusetts Medical School, Worcester 01655.

Abstract

Lymphokine-activated killer (LAK) cells generated from C57BL/6 mouse spleen cells cultured with interleukin-2 are effective prophylactically against virus infection when inoculated at the site of virus injection. To predict the therapeutic efficacy of LAK cells, we determined whether LAK cells would home to sites of virus infection. In vitro, LAK cells responded chemotactically to cell-free peritoneal exudate fluids collected from virus-infected mice and to preparations of purified beta interferon. In vivo, radiolabeled LAK cells injected intravenously accumulated in the peritoneal cavities of intraperitoneally infected mice in amounts three to eight times greater than in uninfected mice. This ability to respond to chemotactic agents and migrate into sites of virus infection may make LAK cells useful as antiviral therapeutic agents.

PMID:
2795722
[PubMed - indexed for MEDLINE]
PMCID:
PMC251148
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk